North America Monoclonal Antibodies Market
The North America Monoclonal Antibodies Market size was valued at US$ 54,629.4 Mn in 2021 and is projected to reach US$ 1,20,713.2 Mn by 2028, growing at a CAGR of 12.0% during 2021 - 2028.
Report Coverage
- Source: Human, Humanized, Chimeric, Murine
- Production Method: In-Vitro, In-Vivo
- Indication: Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases
- Application: Therapeutic Applications, Diagnostic Applications, Research Applications
- End-User: Hospitals, Research Institutes
US$ 54,629.4 Mn
Market size in 2021
US$ 1,20,713.2 Mn
Market Size by 2028
12.0%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Monoclonal Antibodies Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Monoclonal Antibodies Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Monoclonal Antibodies Market Regional Analysis
6.2 North America Monoclonal Antibodies Market Revenue 2019-2028 (US$ Million)
6.3 North America Monoclonal Antibodies Market Forecast Analysis
7. North America Monoclonal Antibodies Market Analysis – by Source
7.1 Human
- 7.1.1 Overview
- 7.1.2 Human: North America Monoclonal Antibodies Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Humanized
- 7.2.1 Overview
- 7.2.2 Humanized: North America Monoclonal Antibodies Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Chimeric
- 7.3.1 Overview
- 7.3.2 Chimeric: North America Monoclonal Antibodies Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Murine
- 7.4.1 Overview
- 7.4.2 Murine: North America Monoclonal Antibodies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. North America Monoclonal Antibodies Market Analysis – by Production Method
8.1 In-Vitro
- 8.1.1 Overview
- 8.1.2 In-Vitro: North America Monoclonal Antibodies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 In-Vivo
- 8.2.1 Overview
- 8.2.2 In-Vivo: North America Monoclonal Antibodies Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. North America Monoclonal Antibodies Market Analysis – by Indication
9.1 Cancer
- 9.1.1 Overview
- 9.1.2 Cancer: North America Monoclonal Antibodies Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Autoimmune Diseases
- 9.2.1 Overview
- 9.2.2 Autoimmune Diseases: North America Monoclonal Antibodies Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Infectious Diseases
- 9.3.1 Overview
- 9.3.2 Infectious Diseases: North America Monoclonal Antibodies Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Inflammatory Diseases
- 9.4.1 Overview
- 9.4.2 Inflammatory Diseases: North America Monoclonal Antibodies Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.5 Microbial Diseases
- 9.5.1 Overview
- 9.5.2 Microbial Diseases: North America Monoclonal Antibodies Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. North America Monoclonal Antibodies Market Analysis – by Application
10.1 Therapeutic Applications
- 10.1.1 Overview
- 10.1.2 Therapeutic Applications: North America Monoclonal Antibodies Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.2 Diagnostic Applications
- 10.2.1 Overview
- 10.2.2 Diagnostic Applications: North America Monoclonal Antibodies Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.3 Research Applications
- 10.3.1 Overview
- 10.3.2 Research Applications: North America Monoclonal Antibodies Market – Revenue and Forecast, 2019-2028 (US$ Million)
11. North America Monoclonal Antibodies Market – North America Analysis
11.1 Overview
11.2 North America- 11.2.1 North America Monoclonal Antibodies Market Breakdown, by Key Country, 2022 and 2028 (%)
- 11.2.1.1 North America Monoclonal Antibodies Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 US: North America Monoclonal Antibodies Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 US: North America Monoclonal Antibodies Market Breakdown, by Source
- 11.2.1.1.2 US: North America Monoclonal Antibodies Market Breakdown, by Production Method
- 11.2.1.1.3 US: North America Monoclonal Antibodies Market Breakdown, by Indication
- 11.2.1.1.4 US: North America Monoclonal Antibodies Market Breakdown, by Application
- 11.2.1.2 Canada: North America Monoclonal Antibodies Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Canada: North America Monoclonal Antibodies Market Breakdown, by Source
- 11.2.1.2.2 Canada: North America Monoclonal Antibodies Market Breakdown, by Production Method
- 11.2.1.2.3 Canada: North America Monoclonal Antibodies Market Breakdown, by Indication
- 11.2.1.2.4 Canada: North America Monoclonal Antibodies Market Breakdown, by Application
- 11.2.1.3 Mexico : North America Monoclonal Antibodies Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 Mexico : North America Monoclonal Antibodies Market Breakdown, by Source
- 11.2.1.3.2 Mexico : North America Monoclonal Antibodies Market Breakdown, by Production Method
- 11.2.1.3.3 Mexico : North America Monoclonal Antibodies Market Breakdown, by Indication
- 11.2.1.3.4 Mexico : North America Monoclonal Antibodies Market Breakdown, by Application
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Novartis AG
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Pfizer Inc.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 GlaxoSmithKline plc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Amgen Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 DAIICHI SANKYO COMPANY, LIMITED
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 F. Hoffmann-La Roche Ltd.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 AstraZeneca
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Eli Lilly and Company
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Bayer AG
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Bristol-Myers Squibb Company
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
